{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:40:23Z","timestamp":1788547223116,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002241","name":"MEXT | Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJMS2024-9"],"award-info":[{"award-number":["JPMJMS2024-9"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Syst Biol Appl"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The pair-wise observation of the input and target values obtained from the same sample is mandatory in any prediction problem. In the biomarker discovery of Alzheimer\u2019s disease (AD), however, obtaining such paired data is laborious and often avoided. Accumulation of amyloid-beta (A\u03b2) in the brain precedes neurodegeneration in AD, and the quantitative accumulation level may reflect disease progression in the very early phase. Nevertheless, the direct observation of A\u03b2 is rarely paired with the observation of other biomarker candidates. To this end, we established a method that quantitatively predicts A\u03b2 accumulation from biomarker candidates by integrating the mostly unpaired observations via a few-shot learning approach. When applied to 5xFAD mouse behavioral data, the proposed method predicted the accumulation level that conformed to the observed amount of A\u03b2 in the samples with paired data. The results suggest that the proposed model can contribute to discovering A\u03b2 predictability-based biomarkers.<\/jats:p>","DOI":"10.1038\/s41540-023-00321-5","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T04:23:34Z","timestamp":1700713414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Few-shot prediction of amyloid \u03b2 accumulation from mainly unpaired data on biomarker candidates"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2277-9951","authenticated-orcid":false,"given":"Yuichiro","family":"Yada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6816-9126","authenticated-orcid":false,"given":"Honda","family":"Naoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"321_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long, J. M. & Holtzman, D. M. Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179, 312\u2013339 (2019).","journal-title":"Cell"},{"key":"321_CR2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman, R. J. et al. Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N. Engl. J. Med. 367, 795\u2013804 (2012).","journal-title":"N. Engl. J. Med."},{"key":"321_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/0891988710383571","volume":"23","author":"LM Bekris","year":"2010","unstructured":"Bekris, L. M., Yu, C.-E., Bird, T. D. & Tsuang, D. W. Genetics of Alzheimer disease. J. Geriatr. Psychiatry Neurol. 23, 213\u2013227 (2010).","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"321_CR4","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"J-C Lambert","year":"2013","unstructured":"Lambert, J.-C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat. Genet. 45, 1452\u20131458 (2013).","journal-title":"Nat. Genet."},{"key":"321_CR5","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat. Genet. 51, 414\u2013430 (2019).","journal-title":"Nat. Genet."},{"key":"321_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen, I. E. et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat. Genet. 51, 404\u2013413 (2019).","journal-title":"Nat. Genet."},{"key":"321_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s43587-021-00158-9","volume":"2","author":"T Kondo","year":"2022","unstructured":"Kondo, T. et al. Dissection of the polygenic architecture of neuronal A\u03b2 production using a large sample of individual iPSC lines derived from Alzheimer\u2019s disease patients. Nat. Aging 2, 125\u2013139 (2022).","journal-title":"Nat. Aging"},{"key":"321_CR8","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","volume":"19","author":"TK Karikari","year":"2020","unstructured":"Karikari, T. K. et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 19, 422\u2013433 (2020).","journal-title":"Lancet Neurol."},{"key":"321_CR9","doi-asserted-by":"publisher","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","volume":"93","author":"SE Schindler","year":"2019","unstructured":"Schindler, S. E. et al. High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis. Neurology 93, e1647\u2013e1659 (2019).","journal-title":"Neurology"},{"key":"321_CR10","doi-asserted-by":"publisher","first-page":"100583","DOI":"10.1016\/j.eclinm.2020.100583","volume":"28","author":"E Eyigoz","year":"2020","unstructured":"Eyigoz, E., Mathur, S., Santamaria, M., Cecchi, G. & Naylor, M. Linguistic markers predict onset of Alzheimer\u2019s disease. EClinicalMedicine 28, 100583 (2020).","journal-title":"EClinicalMedicine"},{"key":"321_CR11","doi-asserted-by":"publisher","first-page":"e12114","DOI":"10.1002\/trc2.12114","volume":"6","author":"MP Vitek","year":"2020","unstructured":"Vitek, M. P. et al. Translational animal models for Alzheimer\u2019s disease: an Alzheimer\u2019s association business consortium think tank. Alzheimers Dement. 6, e12114 (2020).","journal-title":"Alzheimers Dement."},{"key":"321_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.nbd.2013.04.010","volume":"56","author":"JJ Sabbagh","year":"2013","unstructured":"Sabbagh, J. J., Kinney, J. W. & Cummings, J. L. Alzheimer\u2019s disease biomarkers: correspondence between human studies and animal models. Neurobiol. Dis. 56, 116\u2013130 (2013).","journal-title":"Neurobiol. Dis."},{"key":"321_CR13","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.15252\/embj.201797397","volume":"36","author":"H Sasaguri","year":"2017","unstructured":"Sasaguri, H. et al. APP mouse models for Alzheimer\u2019s disease preclinical studies. EMBO J. 36, 2473\u20132487 (2017).","journal-title":"EMBO J."},{"key":"321_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack, C. R. Jr et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 12, 207\u2013216 (2013).","journal-title":"Lancet Neurol."},{"key":"321_CR15","doi-asserted-by":"publisher","first-page":"e1692","DOI":"10.1212\/WNL.0000000000200148","volume":"98","author":"LE Collij","year":"2022","unstructured":"Collij, L. E. et al. Spatial-temporal patterns of \u03b2-amyloid accumulation. Neurology 98, e1692\u2013e1703 (2022).","journal-title":"Neurology"},{"key":"321_CR16","doi-asserted-by":"publisher","first-page":"e1538","DOI":"10.1212\/WNL.0000000000010256","volume":"95","author":"LE Collij","year":"2020","unstructured":"Collij, L. E. et al. Multitracer model for staging cortical amyloid deposition using PET imaging. Neurology 95, e1538\u2013e1553 (2020).","journal-title":"Neurology"},{"key":"321_CR17","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1212\/WNL.0000000000004643","volume":"89","author":"MJ Grothe","year":"2017","unstructured":"Grothe, M. J. et al. In vivo staging of regional amyloid deposition. Neurology 89, 2031\u20132038 (2017).","journal-title":"Neurology"},{"key":"321_CR18","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1212\/WNL.0000000000001991","volume":"85","author":"S Palmqvist","year":"2015","unstructured":"Palmqvist, S. et al. Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease. Neurology 85, 1240\u20131249 (2015).","journal-title":"Neurology"},{"key":"321_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.nicl.2018.01.019","volume":"18","author":"SP Caminiti","year":"2018","unstructured":"Caminiti, S. P. et al. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort. NeuroImage: Clin. 18, 167\u2013177 (2018).","journal-title":"NeuroImage: Clin."},{"key":"321_CR20","doi-asserted-by":"publisher","unstructured":"Therriault, J. et al. Biomarker modeling of Alzheimer\u2019s disease using PET-based Braak staging. Nat. Aging 1\u201310 https:\/\/doi.org\/10.1038\/s43587-022-00204-0 (2022).","DOI":"10.1038\/s43587-022-00204-0"},{"key":"321_CR21","first-page":"1797","volume":"28","author":"M Mil\u00e0-Alom\u00e0","year":"2022","unstructured":"Mil\u00e0-Alom\u00e0, M. et al. Plasma p-tau231 and p-tau217 as state markers of amyloid-\u03b2 pathology in preclinical Alzheimer\u2019s disease. Nat. Med. 28, 1797\u20131801 (2022).","journal-title":"Nat. Med."},{"key":"321_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-021-01054-y","volume":"8","author":"S Forner","year":"2021","unstructured":"Forner, S. et al. Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer\u2019s disease. Sci. Data 8, 270 (2021).","journal-title":"Sci. Data"},{"key":"321_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s40478-015-0252-9","volume":"3","author":"G Xu","year":"2015","unstructured":"Xu, G. et al. Murine A\u03b2 over-production produces diffuse and compact Alzheimer-type amyloid deposits. Acta Neuropathol. Commun. 3, 72 (2015).","journal-title":"Acta Neuropathol. Commun."},{"key":"321_CR24","doi-asserted-by":"publisher","first-page":"196.e29","DOI":"10.1016\/j.neurobiolaging.2010.05.027","volume":"33","author":"S Jawhar","year":"2012","unstructured":"Jawhar, S., Trawicka, A., Jenneckens, C., Bayer, T. A. & Wirths, O. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal A\u03b2 aggregation in the 5XFAD mouse model of Alzheimer\u2019s disease. Neurobiol. Aging 33, 196.e29\u201340 (2012).","journal-title":"Neurobiol. Aging"},{"key":"321_CR25","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-143120","volume":"45","author":"BC Richard","year":"2015","unstructured":"Richard, B. C. et al. Gene dosage dependent aggravation of the neurological phenotype in the 5XFAD mouse model of Alzheimer\u2019s disease. J. Alzheimers Dis. 45, 1223\u20131236 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"321_CR26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","volume":"372","author":"C Holmes","year":"2008","unstructured":"Holmes, C. et al. Long-term effects of A\u03b242 immunisation in Alzheimer\u2019s disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 372, 216\u2013223 (2008).","journal-title":"Lancet"},{"key":"321_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0197-4580(92)90027-U","volume":"13","author":"DW Dickson","year":"1992","unstructured":"Dickson, D. W. et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol. Aging 13, 179\u2013189 (1992).","journal-title":"Neurobiol. Aging"},{"key":"321_CR28","doi-asserted-by":"publisher","first-page":"5161","DOI":"10.1073\/pnas.0600948103","volume":"103","author":"JS Jacobsen","year":"2006","unstructured":"Jacobsen, J. S. et al. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer\u2019s disease. Proc. Natl. Acad. Sci. USA 103, 5161\u20135166 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"321_CR29","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/alz.12140","volume":"16","author":"Z Wang","year":"2020","unstructured":"Wang, Z. et al. AD risk score for the early phases of disease based on unsupervised machine learning. Alzheimers Dement. 16, 1524\u20131533 (2020).","journal-title":"Alzheimers Dement."},{"key":"321_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fdata.2020.00024","volume":"3","author":"LL Raket","year":"2020","unstructured":"Raket, L. L. Statistical disease progression modeling in Alzheimer disease. Front. Big Data 3, 24 (2020).","journal-title":"Front. Big Data"},{"key":"321_CR31","doi-asserted-by":"publisher","first-page":"109581","DOI":"10.1016\/j.jneumeth.2022.109581","volume":"374","author":"C Platero","year":"2022","unstructured":"Platero, C. Categorical predictive and disease progression modeling in the early stage of Alzheimer\u2019s disease. J. Neurosci. Methods 374, 109581 (2022).","journal-title":"J. Neurosci. Methods"},{"key":"321_CR32","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.neuroimage.2016.04.001","volume":"134","author":"M Bilgel","year":"2016","unstructured":"Bilgel, M., Prince, J. L., Wong, D. F., Resnick, S. M. & Jedynak, B. M. A multivariate nonlinear mixed effects model for longitudinal image analysis: application to amyloid imaging. Neuroimage 134, 658\u2013670 (2016).","journal-title":"Neuroimage"},{"key":"321_CR33","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/cpt.1166","volume":"105","author":"T Ishida","year":"2019","unstructured":"Ishida, T. et al. A novel method to estimate long-term chronological changes from fragmented observations in disease progression. Clin. Pharmacol. Ther. 105, 436\u2013447 (2019).","journal-title":"Clin. Pharmacol. Ther."},{"key":"321_CR34","first-page":"2845","volume":"2012","author":"R Sukkar","year":"2012","unstructured":"Sukkar, R., Katz, E., Zhang, Y., Raunig, D. & Wyman, B. T. Disease progression modeling using Hidden Markov Models. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2012, 2845\u20132848 (2012).","journal-title":"Conf. Proc. IEEE Eng. Med. Biol. Soc."},{"key":"321_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/01621459.2019.1594831","volume":"115","author":"JP Williams","year":"2020","unstructured":"Williams, J. P., Storlie, C. B., Therneau, T. M., Clifford, R. J. Jr & Hannig, J. A bayesian approach to multistate hidden markov models: application to dementia progression. J. Am. Stat. Assoc. 115, 16\u201331 (2020).","journal-title":"J. Am. Stat. Assoc."},{"key":"321_CR36","first-page":"3599","volume":"28","author":"Y-Y Liu","year":"2015","unstructured":"Liu, Y.-Y., Li, S., Li, F., Song, L. & Rehg, J. M. Efficient learning of continuous-time hidden markov models for disease progression. Adv. Neural Inf. Process. Syst. 28, 3599\u20133607 (2015).","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"321_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature15369","volume":"525","author":"Z Jaunmuktane","year":"2015","unstructured":"Jaunmuktane, Z. et al. Evidence for human transmission of amyloid-\u03b2 pathology and cerebral amyloid angiopathy. Nature 525, 247\u2013250 (2015).","journal-title":"Nature"},{"key":"321_CR38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s40478-021-01266-8","volume":"9","author":"S Lam","year":"2021","unstructured":"Lam, S. et al. Transmission of amyloid-beta and tau pathologies is associated with cognitive impairments in a primate. Acta Neuropathol. Commun. 9, 165 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"321_CR39","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","volume":"14","author":"H Hampel","year":"2018","unstructured":"Hampel, H. et al. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nat. Rev. Neurol. 14, 639\u2013652 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"321_CR40","doi-asserted-by":"publisher","first-page":"e14408","DOI":"10.15252\/emmm.202114408","volume":"14","author":"A Leuzy","year":"2022","unstructured":"Leuzy, A. et al. Blood-based biomarkers for Alzheimer\u2019s disease. EMBO Mol. Med. 14, e14408 (2022).","journal-title":"EMBO Mol. Med."},{"key":"321_CR41","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1001\/archneurol.2007.56","volume":"65","author":"C Soto","year":"2008","unstructured":"Soto, C. & Estrada, L. D. Protein Misfolding and Neurodegeneration. Arch. Neurol. 65, 184\u2013189 (2008).","journal-title":"Arch. Neurol."},{"key":"321_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0197-0186(02)00196-1","volume":"43","author":"BS Shastry","year":"2003","unstructured":"Shastry, B. S. Neurodegenerative disorders of protein aggregation. Neurochem. Int. 43, 1\u20137 (2003).","journal-title":"Neurochem. Int."},{"key":"321_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00401-017-1709-7","volume":"134","author":"TL Spires-Jones","year":"2017","unstructured":"Spires-Jones, T. L., Attems, J. & Thal, D. R. Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol. 134, 187\u2013205 (2017).","journal-title":"Acta Neuropathol."},{"key":"321_CR44","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/WNL.0b013e3182840bbe","volume":"80","author":"CR Jack Jr","year":"2013","unstructured":"Jack, C. R. Jr et al. Brain \u03b2-amyloid load approaches a plateau. Neurology 80, 890\u2013896 (2013).","journal-title":"Neurology"},{"key":"321_CR45","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/2051-5960-2-30","volume":"2","author":"S Burgold","year":"2014","unstructured":"Burgold, S., Filser, S., Dorostkar, M. M., Schmidt, B. & Herms, J. In vivo imaging reveals sigmoidal growth kinetic of \u03b2-amyloid plaques. Acta Neuropathol. Commun. 2, 30 (2014).","journal-title":"Acta Neuropathol. Commun."}],"container-title":["npj Systems Biology and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41540-023-00321-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-023-00321-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-023-00321-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T05:02:53Z","timestamp":1700715773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41540-023-00321-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["321"],"URL":"https:\/\/doi.org\/10.1038\/s41540-023-00321-5","relation":{},"ISSN":["2056-7189"],"issn-type":[{"value":"2056-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]},"assertion":[{"value":"3 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}